Beirut, Beyrouth, Lebanon In 2010 was created Valquest Partners, which is appeared as VC. The fund was located in Asia if to be more exact in Lebanon. The main office of represented VC is situated in the Beirut.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Valquest Partners, startups are often financed by Sofinnova Partners, Sofimac Partners, Omnes Capital. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Supernova, Omnes Capital.
The high activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
We can highlight the next thriving fund investment areas, such as Biotechnology. For fund there is no match between the country of its foundation and the country of its the most frequent investments - France. Among the various public portfolio startups of the fund, we may underline AFYREN Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
Funds with similar focus
| Fund Name | Location |
| Ag Innovation Development Group | - |
| Ashoka | Arlington, United States, Virginia |
| Broadband Capital Investments | Florida, Miami, United States |
| Celanese | Irving, Texas, United States |
| Fame Mount Limited | - |
| Fuhai Yintao | China, Guangdong, Shenzhen |
| Investion | Amsterdam, Noord-Holland, The Netherlands |
| Joho Capital | New York, New York, United States |
| Kingson Capital Partners | Durban, KwaZulu-Natal, South Africa |
| Live Shark Tank | - |
| Novelion Therapeutics | British Columbia, Canada, Vancouver |
| Ramot | Israel, Tel Aviv, Tel Aviv District |
| RBC | Canada, Ontario, Toronto |
| Savitr Capital | California, San Francisco, United States |
| Stow Capital | - |
| Viva BioInnovator | China, Shanghai |
| Zenyaku Kogyo | Japan, Tokyo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TISSIUM | $46M | 20 Nov 2019 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TISSIUM | $46M | 20 Nov 2019 | Paris, Ile-de-France, France |
